Amundi Stock Slides Towards Its Support at €71.60 Following Two Analyst Downgrades

Impact of Analyst Downgrades

The session was marked by the simultaneous publication of two price target revisions on Amundi. Morgan Stanley reduced its target from €86.60 to €83.00, while maintaining its 'market-weight' recommendation. Citi, on the other hand, lowered its target from €84.50 to €79.50, also maintaining a 'neutral' stance. Despite these adjustments, both targets remain significantly above the current price of €72.50, indicating a potential revaluation of approximately 14.5% and 9.7% respectively. These revisions come three weeks ahead of the first quarter results scheduled for April 29, an event that could provide new insights into the group's collection dynamics and margins. Meanwhile, the CAC 40 is down by 0.48% at 7,924.16 points, and the SBF 120 also falls by 0.48%. In the financial sector, BNP Paribas shows almost stability (+0.08%) and AXA slightly down by 0.17%, placing Amundi among the most pronounced declines in the segment.

Technical Perspective on Stock Performance

From a technical standpoint, the stock is currently priced at €72.50, very close to its identified support at €71.60. This level is a threshold to watch: a downward breach could lead to a further phase of weakness. The 50-day moving average, which stands at €75.99, remains well above the current price, confirming a short-term bearish trend. The stock has also lost 0.75% over the last seven days. Moreover, the price is positioned in the lower part of the Bollinger Bands, at 24% of the range defined between the lower bound (€71.32) and the upper bound (€76.19). This positioning indicates selling pressure that brings the stock closer to its potential oversold zone, although the lower bound has not yet been breached. Over one year, the stock still maintains a positive performance of 15.81%, supported by a 200-day moving average established at €69.62, which is still below the current price.